Granulomatosis with polyangiitis: the vasculitis behind the sinus trouble that would not clear, and the road to remission
Last updated September 3, 2026.
Granulomatosis with polyangiitis, GPA, formerly called Wegener's, is a rare autoimmune vasculitis: the immune system attacks the small blood vessels, and the fallout lands wherever those vessels supply, classically the sinuses and nose, the lungs, and the kidneys. The classic story is months of sinus trouble that would not clear, nosebleeds and crusting, sometimes a collapsed nose bridge, with cough or breathlessness, blood in the urine, and a deep fatigue, before someone runs the blood test that finds it. That test is the ANCA, an antibody that in the right pattern is the fingerprint of this disease, and a biopsy of an affected area confirms it. The stakes of the diagnosis are real and so is the progress: untreated, the kidney and lung damage can be life-threatening, but modern treatment, induction with steroids plus rituximab or cyclophosphamide, then maintenance, puts the large majority into remission, and most people return to full lives. The condition can relapse, so the follow-up is permanent: blood tests and urine checks on a schedule, with flares caught early and re-treated. The infection vigilance matters too, because the medicines that control the disease lower the defenses. The summary for a new diagnosis: rare, serious, and very treatable, with a specialist community that knows it well.
What does it look like?
The head and the chest first: sinus pain and congestion that shrug off antibiotics, nosebleeds and crusting, ear infections, a hoarse voice, sometimes the nose bridge saddling; then the lungs, cough, breathlessness, coughing blood; and the kidneys, often silent until the urine or blood tests speak. Fevers, night sweats, joint pains, and a fatigue out of all proportion usually run underneath. The pattern is a multi-system illness pretending to be sinusitis.
Why does it happen?
The immune system manufactures ANCA antibodies that activate white cells against the walls of small blood vessels, inflaming them and forming the granulomas, the little clusters of inflammatory tissue, that give the disease its name. Why it starts is unknown; it is not inherited in any way family members need to fear, it is not contagious, and nothing done or exposed to is established as the cause. It is an autoimmune misfortune, rare and unchosen.
How is it treated?
- Induction puts out the fire. High-dose steroids plus rituximab or, in some, cyclophosphamide bring the disease under control over weeks to months, and this phase is the intensive one, with close monitoring.
- Maintenance keeps the fire out. Lower-dose immune suppression, continued for years, holds the remission, and the schedule of blood and urine tests exists to catch a flare while it is still small.
- Infection vigilance is the daily discipline. The medicines lower the defenses: fevers are reported promptly, vaccines are kept current on the team's schedule, and the prophylactic antibiotic often prescribed is taken exactly.
- The organ damage gets its own care. Kidneys are tracked on blood and urine tests, the nose and sinuses get ENT care and rinses, and the rare severe kidney or lung case gets plasma exchange or intensive support while the drugs take hold.
When does it need urgent review?
Coughing blood, new breathlessness, tea-colored urine with reduced output, or a fever on immune suppression are each a same-day assessment. A new cluster of nosebleeds, sinus pain, and fatigue after a quiet period deserves a prompt flare review. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
How was this missed as sinusitis for eight months?
Through resemblance, not carelessness, and your story is the standard opening chapter of this disease. Vasculitis of the sinuses looks exactly like infection: congestion, pain, discharge, and the first, second, and third courses of antibiotics are the reasonable responses to it. The picture declares itself only when the ordinary rules break, the sinusitis that never clears, the nose bridge changing, the blood in the cough, and that is when someone runs the ANCA. Nearly every person with GPA has a version of your eight months. The lesson worth keeping is the forward one: you now know your flare pattern, and a returning cluster of it earns a prompt review rather than a fourth course.
What is the ANCA test, and does positive definitely mean this?
ANCA is an antibody blood test, and in this disease the immune system makes antibodies that activate white blood cells against the walls of small blood vessels. In the right pattern, and especially paired with your story, it is close to a fingerprint, which is why the rheumatologist ran it; the kidney biopsy then made it certain by showing the inflamed vessels and granulomas directly. The test matters beyond the diagnosis too: in many people the ANCA level tracks the disease's activity, so it becomes one of the numbers your follow-up watches. A test that finds the disease and then keeps watch over it is doing double duty for you.
Will my kidneys recover?
Often substantially, and the timing favors you: kidney damage in this condition comes from active inflammation, and the treatment starting next week stops that inflammation, which is why function so often improves over the following months once the fire is out. The honest range: some people recover fully, some are left with a degree of chronic kidney disease that is then protected and watched, and the difference only reveals itself in the numbers over the coming months. The kidney-protective habits are the same either way: blood pressure controlled, the urine checks kept, the kidney-stressing painkillers avoided, and every follow-up attended. Your kidneys are being treated now, and that is the thing that changes the trajectory.
What are the steroids going to do to me?
The honest list, because it is better heard than discovered: at high doses, expect a bigger appetite, broken sleep, mood swings that surprise you, a puffier face, and energy that runs hot and cold. They track the dose, they retreat as the dose tapers, and none of them is permanent. Two rules make them bearable: report rather than absorb, because some effects are worth managing in their own right, and never stop them suddenly, because the body needs the taper. The steroid weeks are the price of the fire going out, and the team that has watched a thousand people pay it will not be surprised by anything you report.
Can this come back after remission?
It can, and the follow-up system exists precisely so that a relapse is a small event rather than a catastrophe. The schedule of blood and urine tests, plus the ANCA level in many people, catches a flare while it is still laboratory-small, and flares caught there are re-treated before they cost organs. The symptoms to know are the ones you already met: the sinus cluster, nosebleeds, the cough, the deep fatigue, returning together after a quiet period. Most people have zero or one significant relapse over the years, each managed, and the long-term picture for most is a life lived in remission with a disease on a shelf in the back of the mind.
Is my family at risk? Should anyone be tested?
No, on both counts, and it is a clean answer. GPA is not inherited in any way that matters: family members carry no meaningful extra risk, there is no gene to pass on, and there is no screening test anyone else needs. It is not contagious, and nothing you were exposed to is established as the cause, so there is also no household change to make. The only inheritance worth passing down from your eight months is knowledge: an autoimmune vasculitis exists, it hides as sinusitis, and an ANCA test finds it. That sentence, known in your family, is protection enough.